Diagnostic Utility of the Gilliam Autism Rating Scales-3rd Edition Parent Report in Clinically Referred Children.
The GARS-3 Parent Report gives accurate autism flags for clinic-referred kids, backing the trend that brief parent checklists can stand in for long interviews.
01Research in Context
What this study did
Camodeca (2023) tested the Gilliam Autism Rating Scale-3 Parent Report. The team wanted to know if this parent form gives clear yes-or-no answers for kids sent to a clinic.
They looked at sensitivity, specificity, and agreement with other tools. The sample was 90 boys and young men already in the referral stream.
What they found
The scale showed good to excellent inter-rater agreement. Sensitivity and specificity were strong, and scores lined up well with other autism measures.
In plain words, when parents filled out the GARS-3, the numbers usually matched what clinicians later decided.
How this fits with other research
Lord et al. (1997) set the groundwork by showing the ADI-R interview works across ages. Camodeca (2023) keeps that lineage but swaps the long interview for a short parent checklist.
Ferreri et al. (2011) found the 15-minute CASD and SRS parent forms agreed with the 2-hour ADI-R over 90 % of the time. Amy’s results echo that speed does not have to hurt accuracy.
Payne et al. (2020) saw the parent-report AQ-Adult-HK beat the self-report version. Amy adds another parent form that wins on the same metrics, tightening the case that parents often give the clearest picture.
Why it matters
You now have one more parent scale that is fast, free from clinician bias, and holds up psychometrically. Use it during intake to screen clinic referrals or to double-check your own ADOS findings. If the parent GARS-3 score is high, move the case up the queue; if it is low but you still suspect ASD, keep digging. The tool saves interview minutes without trashing validity.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add the GARS-3 parent form to your intake packet and set a cut-score that triggers a full ADOS.
02At a glance
03Original abstract
For autism spectrum disorder (ASD) in adults there are several diagnostic instruments available with a need for consideration of the psychometric properties. This study aimed to conduct a first psychometric evaluation of a new diagnostic ASD instrument, the NIDA (Dutch Interview for Diagnostic assessment of ASD in adults) in 90 adult males without intellectual disability (age 18-65 years) in the Netherlands: 30 with ASD, 30 with a Personality Disorder and 30 nonpatient controls. The interrater agreement ranged from 0.79 to 1.00, the convergent validity including sensitivity and specificity ranged from 0.76 to 1.00, and we observed an adequate concurrent criterion-related validity. These promising findings can serve as foundation for future psychometric NIDA studies in a more diverse population. TRIAL REGISTRATION: The Netherlands National Trial Register NTR6391. Registered 04 May 2017.
Journal of autism and developmental disorders, 2023 · doi:10.1007/s00787-015-0793-2